Independent company use-case study · specialty chemicals and CDMO

EvonikFive process decisions

Choose one use case. Add authorised plant data. Test capacity, cost and constraints.
Acatian flowsheet workspace for a Evonik process decision
Assumptions, equipment, capacity, cost and evidence on one model basis.

Decision brief

One question. One model.

Decision

Advance one route, scale, facility or campaign option only after product quality, scale robustness, equipment fit, finite resources, economics, environmental inventory and technology-transfer evidence remain consistent.

System boundary

Authorised starting materials or fermentation feed through reaction or cultivation, separation, purification, concentration, drying or formulation, cleaning, utilities, quality holds, waste, transfer and released product.

Five practical use cases

Five places to start.

Evaluation scopes for Evonik—not claims of current software use.
01

Compare fermentation and downstream routes

Connect strain or host assumptions, medium, cultivation, cell separation, purification, concentration and formulation on one material, quality, equipment and uncertainty basis.

02

Screen pilot-to-commercial scale-up

Translate pilot evidence into mixing, oxygen-transfer, heat-removal and downstream-load envelopes, then test requirements against customer-authorised equipment, room and utility limits.

03

Test multi-product CDMO campaigns offline

Schedule eligible reactors or fermenters, downstream assets, cleaning, containment, materials, laboratories and release holds without representing Evonik's actual customers, capacity or commitments.

04

Compare route economics and lifecycle inventory

Evaluate fermentative, chemical or hybrid options across yield, raw materials, solvents, energy, water, waste, capital and operating cost under the same functional unit and boundary.

05

Govern technology-transfer evidence

Link source and target versions, scale assumptions, risks, analytical methods, engineering runs, deviations and acceptance criteria while separating model checks from formal GMP validation.

Action pack

Inputs in. Decisions out.

Minimum inputs
  • Product, organism or chemistry, quality and demand basis
  • Kinetic, titer, recovery, reaction and pilot evidence
  • Equipment eligibility, scale rules, hold times and site limits
  • Materials, solvents, utilities, waste, cost and environmental factors
Required outputs
  • Route and end-to-end process comparison
  • Scale-up and facility-fit evidence map
  • Finite campaign schedule and released-capacity range
  • TEA/LCA screen and transfer-readiness register
First three steps
  • Select one authorised product, route or transfer decision.
  • Declare quality, process, containment and facility boundaries.
  • Import development, pilot and equipment evidence.

Evidence and limits

Public evidence only.

  1. Evonik — Strain and process developmentOfficial context for microbial strain, upstream and downstream process development across fermentation product classes.
  2. Evonik — Fermentation scale-up and pilotingOfficial context for piloting, scale-up, continuous processing and support toward launch.
  3. Evonik — Sustainability analysesOfficial context for lifecycle assessment purpose, system boundaries, impact categories, standards and review.
  4. Evonik — Process validation and regulatory supportOfficial context for process-validation and regulatory dossier support in API CDMO work.

Guardrail: No Evonik customer, strain, molecule, process, site, campaign, capacity, yield, cost, environmental result, deployment or digital system is represented. Process safety, technology transfer, validation, GxP, regulatory and commercial decisions remain under approved Evonik and customer systems.